Schedule 13G ownership disclosure
Perspective Therapeutics Inc
Common Stock, $0.001 par value · CUSIP: 46489V302
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avidity Partners Management LP
Shares: 2,841,024.00 · Class: 4.2%
- Avidity Partners Management (GP) LLC
Shares: 2,841,024.00 · Class: 4.2%
- Avidity Capital Partners Fund (GP) LP
Shares: 2,841,024.00 · Class: 4.2%
- Avidity Capital Partners (GP) LLC
Shares: 2,841,024.00 · Class: 4.2%
- David Witzke
Shares: 0.00 · Class: 0.0%
- Michael Gregory
Shares: 2,841,024.00 · Class: 4.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001388
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership